Disclaimer statement
Warning!
Falsified medicines
The risks and how to spot a falsified medicine
Patient safety is our top priority, and we are committed to supporting the active fight against falsified Novo Nordisk medicines and other illegal activity in the market.
Our position on falsified medicines
We are proactively combating falsified medicines. Through constantly reinforced security measures and collaboration with authorities and industry peers, we strive to protect patient’s health and ensure the integrity of our products.
Investors
Share price
Latest news
03 April 2025
Novo Nordisk announces changes in Executive Management
Read more
29 March 2025
Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
Read more
27 March 2025
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Read more
Career Opportunities
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.
We offer 956 job opportunities